Page last updated: 2024-11-10

methysticin

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

methysticin: a neuroprotective constituent of kava extract; RN given for (R-(E))-isomer [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID90125683
CHEBI ID174607
SCHEMBL ID15678379
MeSH IDM0206622
PubMed CID5281567
CHEMBL ID579224
CHEBI ID6895
SCHEMBL ID1393508
MeSH IDM0206622

Synonyms (55)

Synonym
2-[(z)-2-(1,3-benzodioxol-5-yl)ethenyl]-4-methoxy-2,3-dihydropyran-6-one
(r)-methysticin
CHEBI:174607
methysticin
SCHEMBL15678379
brn 0091701
4-methoxy-6-(beta-(3',4'-methylenedioxyphenyl)vinyl)-5,6-dihydro-alpha-pyrone
2h-pyran-2-one, 5,6-dihydro-4-methoxy-6-(3,4-(methylenedioxy)styryl)-, (r)-
nsc 112158
2h-pyran-2-one, 6-(2-(1,3-benzodioxol-5-yl)ethenyl)-5,6-dihydro-4-methoxy-, (r-(e))-
(r)-5,6-dihydro-4-methoxy-6-(3,4-(methylenedioxy)styryl)-2h-pyran-2-one
(r-(e))-6-(2-(1,3-benzodioxol-5-yl)ethenyl)-5,6-dihydro-4-methoxy-2h-pyran-2-one
5-hydroxy-3-methoxy-7-(3,4-(methylenedioxy)phenyl)-2,6-heptadienoic acid gamma-lactone
2h-pyran-2-one, 5,6-dihydro-4-methoxy-6-(3,4-(methylenedioxy)styryl)-, (r)- (van)
2h-pyran-2-one,6-dihydro-4-methoxy-6-[3,4-(methylenedioxy)styryl]-, (r)-
2h-pyran-2-one,3-benzodioxol-5-yl)ethenyl]-5,6-dihydro-4-methoxy-, [r-(e)]-
2h-pyran-2-one,6-dihydro-4-methoxy-6-[3,4-(methylenedioxy)styryl]-, (+)-
nsc112158
(+)-methysticin
kavatin
495-85-2
kavahin
nsc-112158
NCGC00091903-01
C09952
(6r)-6-[(e)-2-(1,3-benzodioxol-5-yl)vinyl]-4-methoxy-5,6-dihydro-2h-pyran-2-one
chebi:6895 ,
CHEMBL579224
methylsticin
NCGC00091903-02
(2r)-2-[(e)-2-(1,3-benzodioxol-5-yl)ethenyl]-4-methoxy-2,3-dihydropyran-6-one
cas-495-85-2
NCGC00258455-01
dtxcid3013674
dtxsid5033674 ,
tox21_200901
A827756
m832aij6hx ,
5-19-10-00456 (beilstein handbook reference)
ccris 9370
unii-m832aij6hx
2h-pyran-2-one,6-[(1e)-2-(1,3-benzodioxol-5-yl)ethenyl]-5,6-dihydro-4-methoxy-, (6r)-
methysticin [mi]
6-(3',4'-methylenedioxystyryl)-4-methoxy-5,6-dihydro-2h-pyran-2-one
(6r)-6-((1e)-2-(1,3-benzodioxol-5-yl)ethenyl)-5,6-dihydro-4-methoxy-2h-pyran-2-one
SCHEMBL1393508
AC-34499
(2r)-2-[(e)-2-(1,3-benzodioxol-5-yl)vinyl]-4-methoxy-2,3-dihydropyran-6-one
r-(+)-methysticin, analytical standard
AKOS030573530
Q3333720
ethyl 2-(isobutoxycarbonylamino)acetate
(r,e)-6-(2-(benzo[d][1,3]dioxol-5-yl)vinyl)-4-methoxy-5,6-dihydro-2h-pyran-2-one
r-(+)-methysticin
(6r)-6-(2-benzo[1,3]dioxol-5-ylethenyl)-4-methoxy-5,6-dihydropyran-2-one

Research Excerpts

Toxicity

ExcerptReferenceRelevance
" Thus, in vitro kava does not appear to be activated to toxic metabolites by enzymes known to be important in metabolic toxicity."( Kava does not display metabolic toxicity in a homogeneous cellular assay.
Dike, LE; Harkey, MR; Henderson, GL; Zou, L, 2004
)
0.32

Bioavailability

ExcerptReferenceRelevance
"To examine the bioavailability of kavalactones in vitro and the possible differences in their bioavailability because of variations in either chemical structure or the method of extraction used."( Permeability studies of Kavalactones using a Caco-2 cell monolayer model.
Blanchfield, JT; Bone, KM; Lehmann, RP; Matthias, A; Penman, KG; Toth, I, 2007
)
0.34
"Caco-2 cell monolayers were used to determine the potential bioavailability of kavalactones."( Permeability studies of Kavalactones using a Caco-2 cell monolayer model.
Blanchfield, JT; Bone, KM; Lehmann, RP; Matthias, A; Penman, KG; Toth, I, 2007
)
0.34
" Not all differences in their bioavailability can be related to kavalactone structural differences as it appears that bioavailability may also be affected by co-extracted compounds."( Permeability studies of Kavalactones using a Caco-2 cell monolayer model.
Blanchfield, JT; Bone, KM; Lehmann, RP; Matthias, A; Penman, KG; Toth, I, 2007
)
0.34
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (2)

ClassDescription
aromatic etherAny ether in which the oxygen is attached to at least one aryl substituent.
2-pyranonesA pyranone based on the structure of 2H-pyran-2-one and its substituted derivatives.
2-pyranonesA pyranone based on the structure of 2H-pyran-2-one and its substituted derivatives.
aromatic etherAny ether in which the oxygen is attached to at least one aryl substituent.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (45)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
LuciferasePhotinus pyralis (common eastern firefly)Potency60.58690.007215.758889.3584AID1224835
pregnane X receptorRattus norvegicus (Norway rat)Potency31.62280.025127.9203501.1870AID651751
GLI family zinc finger 3Homo sapiens (human)Potency15.99840.000714.592883.7951AID1259369; AID1259392
AR proteinHomo sapiens (human)Potency12.61510.000221.22318,912.5098AID1259243; AID1259247; AID1259381; AID743036; AID743053; AID743054
caspase 7, apoptosis-related cysteine proteaseHomo sapiens (human)Potency20.76690.013326.981070.7614AID1346978
aldehyde dehydrogenase 1 family, member A1Homo sapiens (human)Potency25.11890.011212.4002100.0000AID1030
thyroid stimulating hormone receptorHomo sapiens (human)Potency39.81070.001318.074339.8107AID926; AID938
estrogen receptor 2 (ER beta)Homo sapiens (human)Potency47.50230.000657.913322,387.1992AID1259377; AID1259378
nuclear receptor subfamily 1, group I, member 3Homo sapiens (human)Potency5.08310.001022.650876.6163AID1224838; AID1224839; AID1224893
progesterone receptorHomo sapiens (human)Potency46.49120.000417.946075.1148AID1346795
retinoic acid nuclear receptor alpha variant 1Homo sapiens (human)Potency7.06010.003041.611522,387.1992AID1159552; AID1159555
retinoid X nuclear receptor alphaHomo sapiens (human)Potency26.46900.000817.505159.3239AID1159527; AID1159531; AID588544
estrogen-related nuclear receptor alphaHomo sapiens (human)Potency20.60590.001530.607315,848.9004AID1224841; AID1224842; AID1224848; AID1224849; AID1259401; AID1259403
farnesoid X nuclear receptorHomo sapiens (human)Potency43.34680.375827.485161.6524AID588526; AID743220
pregnane X nuclear receptorHomo sapiens (human)Potency0.89130.005428.02631,258.9301AID720659
estrogen nuclear receptor alphaHomo sapiens (human)Potency7.64330.000229.305416,493.5996AID1259244; AID1259248; AID743069; AID743075; AID743080; AID743091
vitamin D (1,25- dihydroxyvitamin D3) receptorHomo sapiens (human)Potency52.60350.023723.228263.5986AID743222
caspase-3Homo sapiens (human)Potency20.76690.013326.981070.7614AID1346978
aryl hydrocarbon receptorHomo sapiens (human)Potency0.41440.000723.06741,258.9301AID743085; AID743122
cellular tumor antigen p53 isoform aHomo sapiens (human)Potency12.58930.316212.443531.6228AID902
thyroid hormone receptor beta isoform 2Rattus norvegicus (Norway rat)Potency0.05160.000323.4451159.6830AID743065; AID743067
histone deacetylase 9 isoform 3Homo sapiens (human)Potency23.30080.037617.082361.1927AID1259364; AID1259388
nuclear factor erythroid 2-related factor 2 isoform 1Homo sapiens (human)Potency30.13920.000627.21521,122.0200AID651741; AID720636; AID743219
nuclear receptor ROR-gamma isoform 1Mus musculus (house mouse)Potency0.12590.00798.23321,122.0200AID2551
survival motor neuron protein isoform dHomo sapiens (human)Potency5.01190.125912.234435.4813AID1458
cytochrome P450 3A4 isoform 1Homo sapiens (human)Potency2.51190.031610.279239.8107AID884; AID885
Gamma-aminobutyric acid receptor subunit piRattus norvegicus (Norway rat)Potency2.51191.000012.224831.6228AID885
Voltage-dependent calcium channel gamma-2 subunitMus musculus (house mouse)Potency0.92760.001557.789015,848.9004AID1259244
Gamma-aminobutyric acid receptor subunit beta-1Rattus norvegicus (Norway rat)Potency2.51191.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit deltaRattus norvegicus (Norway rat)Potency2.51191.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit gamma-2Rattus norvegicus (Norway rat)Potency2.51191.000012.224831.6228AID885
Glutamate receptor 2Rattus norvegicus (Norway rat)Potency0.92760.001551.739315,848.9004AID1259244
Gamma-aminobutyric acid receptor subunit alpha-5Rattus norvegicus (Norway rat)Potency2.51191.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit alpha-3Rattus norvegicus (Norway rat)Potency2.51191.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit gamma-1Rattus norvegicus (Norway rat)Potency2.51191.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit alpha-2Rattus norvegicus (Norway rat)Potency2.51191.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit alpha-4Rattus norvegicus (Norway rat)Potency2.51191.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit gamma-3Rattus norvegicus (Norway rat)Potency2.51191.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit alpha-6Rattus norvegicus (Norway rat)Potency2.51191.000012.224831.6228AID885
Nuclear receptor ROR-gammaHomo sapiens (human)Potency0.08410.026622.448266.8242AID651802
Gamma-aminobutyric acid receptor subunit alpha-1Rattus norvegicus (Norway rat)Potency2.51191.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit beta-3Rattus norvegicus (Norway rat)Potency2.51191.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit beta-2Rattus norvegicus (Norway rat)Potency2.51191.000012.224831.6228AID885
GABA theta subunitRattus norvegicus (Norway rat)Potency2.51191.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit epsilonRattus norvegicus (Norway rat)Potency2.51191.000012.224831.6228AID885
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (13)

Processvia Protein(s)Taxonomy
negative regulation of transcription by RNA polymerase IINuclear receptor ROR-gammaHomo sapiens (human)
xenobiotic metabolic processNuclear receptor ROR-gammaHomo sapiens (human)
regulation of glucose metabolic processNuclear receptor ROR-gammaHomo sapiens (human)
regulation of steroid metabolic processNuclear receptor ROR-gammaHomo sapiens (human)
intracellular receptor signaling pathwayNuclear receptor ROR-gammaHomo sapiens (human)
circadian regulation of gene expressionNuclear receptor ROR-gammaHomo sapiens (human)
cellular response to sterolNuclear receptor ROR-gammaHomo sapiens (human)
positive regulation of circadian rhythmNuclear receptor ROR-gammaHomo sapiens (human)
regulation of fat cell differentiationNuclear receptor ROR-gammaHomo sapiens (human)
positive regulation of DNA-templated transcriptionNuclear receptor ROR-gammaHomo sapiens (human)
adipose tissue developmentNuclear receptor ROR-gammaHomo sapiens (human)
T-helper 17 cell differentiationNuclear receptor ROR-gammaHomo sapiens (human)
regulation of transcription by RNA polymerase IINuclear receptor ROR-gammaHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (10)

Processvia Protein(s)Taxonomy
RNA polymerase II cis-regulatory region sequence-specific DNA bindingNuclear receptor ROR-gammaHomo sapiens (human)
DNA-binding transcription factor activity, RNA polymerase II-specificNuclear receptor ROR-gammaHomo sapiens (human)
DNA-binding transcription repressor activity, RNA polymerase II-specificNuclear receptor ROR-gammaHomo sapiens (human)
DNA-binding transcription factor activityNuclear receptor ROR-gammaHomo sapiens (human)
protein bindingNuclear receptor ROR-gammaHomo sapiens (human)
oxysterol bindingNuclear receptor ROR-gammaHomo sapiens (human)
zinc ion bindingNuclear receptor ROR-gammaHomo sapiens (human)
ligand-activated transcription factor activityNuclear receptor ROR-gammaHomo sapiens (human)
sequence-specific double-stranded DNA bindingNuclear receptor ROR-gammaHomo sapiens (human)
nuclear receptor activityNuclear receptor ROR-gammaHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (5)

Processvia Protein(s)Taxonomy
plasma membraneGamma-aminobutyric acid receptor subunit gamma-2Rattus norvegicus (Norway rat)
plasma membraneGlutamate receptor 2Rattus norvegicus (Norway rat)
nucleusNuclear receptor ROR-gammaHomo sapiens (human)
nucleoplasmNuclear receptor ROR-gammaHomo sapiens (human)
nuclear bodyNuclear receptor ROR-gammaHomo sapiens (human)
chromatinNuclear receptor ROR-gammaHomo sapiens (human)
nucleusNuclear receptor ROR-gammaHomo sapiens (human)
plasma membraneGamma-aminobutyric acid receptor subunit alpha-1Rattus norvegicus (Norway rat)
plasma membraneGamma-aminobutyric acid receptor subunit beta-2Rattus norvegicus (Norway rat)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (35)

Assay IDTitleYearJournalArticle
AID1090316Herbicidal activity against Echinochloa crus-galli (barnyard grass) assessed as inhibition of root length at 1 ppm relative to untreated control2006Journal of agricultural and food chemistry, Feb-08, Volume: 54, Issue:3
Herbicidal and Fungicidal Activities of Lactones in Kava (Piper methysticum).
AID1090304Herbicidal activity against Lactuca sativa cv. Great Lakes 366 (lettuce) assessed as inhibition of shoot length at 1 ppm relative to untreated control2006Journal of agricultural and food chemistry, Feb-08, Volume: 54, Issue:3
Herbicidal and Fungicidal Activities of Lactones in Kava (Piper methysticum).
AID1090300Herbicidal activity against Echinochloa crus-galli (barnyard grass) assessed as inhibition of germination at 1 ppm relative to untreated control2006Journal of agricultural and food chemistry, Feb-08, Volume: 54, Issue:3
Herbicidal and Fungicidal Activities of Lactones in Kava (Piper methysticum).
AID1090309Antifungal activity against Fusarium oxysporum assessed as growth inhibition at 50 ppm after 4 days relative to untreated control2006Journal of agricultural and food chemistry, Feb-08, Volume: 54, Issue:3
Herbicidal and Fungicidal Activities of Lactones in Kava (Piper methysticum).
AID1090305Herbicidal activity against Lactuca sativa cv. Great Lakes 366 (lettuce) assessed as inhibition of germination at 10 ppm relative to untreated control2006Journal of agricultural and food chemistry, Feb-08, Volume: 54, Issue:3
Herbicidal and Fungicidal Activities of Lactones in Kava (Piper methysticum).
AID447716Hepatotoxicity against mouse Hepa-1c1c7 cells after 48 hrs by celltiter blue assay2009Bioorganic & medicinal chemistry letters, Oct-01, Volume: 19, Issue:19
Identification of methysticin as a potent and non-toxic NF-kappaB inhibitor from kava, potentially responsible for kava's chemopreventive activity.
AID1090314Antifungal activity against Colletotrichum gloeosporioides assessed as growth inhibition at 10 ppm after 4 days relative to untreated control2006Journal of agricultural and food chemistry, Feb-08, Volume: 54, Issue:3
Herbicidal and Fungicidal Activities of Lactones in Kava (Piper methysticum).
AID697853Inhibition of horse BChE at 2 mg/ml by Ellman's method2012Bioorganic & medicinal chemistry, Nov-15, Volume: 20, Issue:22
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
AID1090308Antifungal activity against Hypocrea rufa assessed as growth inhibition at 50 ppm after 4 days relative to untreated control2006Journal of agricultural and food chemistry, Feb-08, Volume: 54, Issue:3
Herbicidal and Fungicidal Activities of Lactones in Kava (Piper methysticum).
AID447712Inhibition of NF-kappaB expressed in human A549 cells assessed as suppression of TNF-alpha-induced IKKalpha level at 25 uM after 7 hrs by Western blotting2009Bioorganic & medicinal chemistry letters, Oct-01, Volume: 19, Issue:19
Identification of methysticin as a potent and non-toxic NF-kappaB inhibitor from kava, potentially responsible for kava's chemopreventive activity.
AID1090306Herbicidal activity against Lactuca sativa cv. Great Lakes 366 (lettuce) assessed as inhibition of germination at 1 ppm relative to untreated control2006Journal of agricultural and food chemistry, Feb-08, Volume: 54, Issue:3
Herbicidal and Fungicidal Activities of Lactones in Kava (Piper methysticum).
AID447713Inhibition of NF-kappaB expressed in human A549 cells assessed as suppression of TNF-alpha-induced p65 level at 25 uM after 7 hrs by Western blotting2009Bioorganic & medicinal chemistry letters, Oct-01, Volume: 19, Issue:19
Identification of methysticin as a potent and non-toxic NF-kappaB inhibitor from kava, potentially responsible for kava's chemopreventive activity.
AID1090311Antifungal activity against Fusarium solani assessed as growth inhibition at 50 ppm after 4 days relative to untreated control2006Journal of agricultural and food chemistry, Feb-08, Volume: 54, Issue:3
Herbicidal and Fungicidal Activities of Lactones in Kava (Piper methysticum).
AID481210Activation of Nrf2 in rat PC12 cells at 10 uM after 24 hrs by antioxidant response element-driven luciferase reporter gene assay2010Bioorganic & medicinal chemistry, May-01, Volume: 18, Issue:9
A novel kavalactone derivative protects against H2O2-induced PC12 cell death via Nrf2/ARE activation.
AID1090310Antifungal activity against Fusarium oxysporum assessed as growth inhibition at 10 ppm after 4 days relative to untreated control2006Journal of agricultural and food chemistry, Feb-08, Volume: 54, Issue:3
Herbicidal and Fungicidal Activities of Lactones in Kava (Piper methysticum).
AID447718Toxicity against human HL60 cells after 48 hrs by celltiter blue assay2009Bioorganic & medicinal chemistry letters, Oct-01, Volume: 19, Issue:19
Identification of methysticin as a potent and non-toxic NF-kappaB inhibitor from kava, potentially responsible for kava's chemopreventive activity.
AID697852Inhibition of electric eel AChE at 2 mg/ml by Ellman's method2012Bioorganic & medicinal chemistry, Nov-15, Volume: 20, Issue:22
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
AID1090303Herbicidal activity against Lactuca sativa cv. Great Lakes 366 (lettuce) assessed as inhibition of shoot length at 10 ppm relative to untreated control2006Journal of agricultural and food chemistry, Feb-08, Volume: 54, Issue:3
Herbicidal and Fungicidal Activities of Lactones in Kava (Piper methysticum).
AID666151Inhibition of PA endonuclease at 1 uM2011PloS one, , Volume: 6, Issue:5
Anti-influenza activity of marchantins, macrocyclic bisbibenzyls contained in liverworts.
AID1090317Herbicidal activity against Echinochloa crus-galli (barnyard grass) assessed as inhibition of shoot length at 10 ppm relative to untreated control2006Journal of agricultural and food chemistry, Feb-08, Volume: 54, Issue:3
Herbicidal and Fungicidal Activities of Lactones in Kava (Piper methysticum).
AID1090301Herbicidal activity against Lactuca sativa cv. Great Lakes 366 (lettuce) assessed as inhibition of root length at 10 ppm relative to untreated control2006Journal of agricultural and food chemistry, Feb-08, Volume: 54, Issue:3
Herbicidal and Fungicidal Activities of Lactones in Kava (Piper methysticum).
AID1090312Antifungal activity against Fusarium solani assessed as growth inhibition at 10 ppm after 4 days relative to untreated control2006Journal of agricultural and food chemistry, Feb-08, Volume: 54, Issue:3
Herbicidal and Fungicidal Activities of Lactones in Kava (Piper methysticum).
AID1090315Herbicidal activity against Echinochloa crus-galli (barnyard grass) assessed as inhibition of root length at 10 ppm relative to untreated control2006Journal of agricultural and food chemistry, Feb-08, Volume: 54, Issue:3
Herbicidal and Fungicidal Activities of Lactones in Kava (Piper methysticum).
AID447717Hepatotoxicity against human A549 cells after 48 hrs by celltiter blue assay2009Bioorganic & medicinal chemistry letters, Oct-01, Volume: 19, Issue:19
Identification of methysticin as a potent and non-toxic NF-kappaB inhibitor from kava, potentially responsible for kava's chemopreventive activity.
AID447719Toxicity against human CCRF-CEM cells after 48 hrs by celltiter blue assay2009Bioorganic & medicinal chemistry letters, Oct-01, Volume: 19, Issue:19
Identification of methysticin as a potent and non-toxic NF-kappaB inhibitor from kava, potentially responsible for kava's chemopreventive activity.
AID447711Inhibition of TNF-alpha-induced NF-kappaB expressed in human A549 cells treated 1 hr after TNFalpha challenge measured after 6 hrs by luciferase reporter gene assay2009Bioorganic & medicinal chemistry letters, Oct-01, Volume: 19, Issue:19
Identification of methysticin as a potent and non-toxic NF-kappaB inhibitor from kava, potentially responsible for kava's chemopreventive activity.
AID1090313Antifungal activity against Colletotrichum gloeosporioides assessed as growth inhibition at 50 ppm after 4 days relative to untreated control2006Journal of agricultural and food chemistry, Feb-08, Volume: 54, Issue:3
Herbicidal and Fungicidal Activities of Lactones in Kava (Piper methysticum).
AID447714Inhibition of NF-kappaB expressed in human A549 cells assessed as suppression of TNF-alpha-induced COX2 level at 25 uM after 7 hrs by Western blotting2009Bioorganic & medicinal chemistry letters, Oct-01, Volume: 19, Issue:19
Identification of methysticin as a potent and non-toxic NF-kappaB inhibitor from kava, potentially responsible for kava's chemopreventive activity.
AID1090299Herbicidal activity against Echinochloa crus-galli (barnyard grass) assessed as inhibition of germination at 10 ppm relative to untreated control2006Journal of agricultural and food chemistry, Feb-08, Volume: 54, Issue:3
Herbicidal and Fungicidal Activities of Lactones in Kava (Piper methysticum).
AID1090302Herbicidal activity against Lactuca sativa cv. Great Lakes 366 (lettuce) assessed as inhibition of root length at 1 ppm relative to untreated control2006Journal of agricultural and food chemistry, Feb-08, Volume: 54, Issue:3
Herbicidal and Fungicidal Activities of Lactones in Kava (Piper methysticum).
AID481211Induction of HO-1 protein expression in rat PC12 cells at 10 uM after 24 hrs by Western blot analysis2010Bioorganic & medicinal chemistry, May-01, Volume: 18, Issue:9
A novel kavalactone derivative protects against H2O2-induced PC12 cell death via Nrf2/ARE activation.
AID1090298Herbicidal activity against Echinochloa crus-galli (barnyard grass) assessed as inhibition of shoot length at 1 ppm relative to untreated control2006Journal of agricultural and food chemistry, Feb-08, Volume: 54, Issue:3
Herbicidal and Fungicidal Activities of Lactones in Kava (Piper methysticum).
AID447715Inhibition of NF-kappaB expressed in human A549 cells assessed as prevention of TNF-alpha-induced IkappaBalpha degradation level at 25 uM after 7 hrs by Western blotting2009Bioorganic & medicinal chemistry letters, Oct-01, Volume: 19, Issue:19
Identification of methysticin as a potent and non-toxic NF-kappaB inhibitor from kava, potentially responsible for kava's chemopreventive activity.
AID1090307Antifungal activity against Hypocrea rufa assessed as growth inhibition at 10 ppm after 4 days relative to untreated control2006Journal of agricultural and food chemistry, Feb-08, Volume: 54, Issue:3
Herbicidal and Fungicidal Activities of Lactones in Kava (Piper methysticum).
AID666150Inhibition of PA endonuclease at 10 uM2011PloS one, , Volume: 6, Issue:5
Anti-influenza activity of marchantins, macrocyclic bisbibenzyls contained in liverworts.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (33)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's5 (15.15)18.2507
2000's12 (36.36)29.6817
2010's13 (39.39)24.3611
2020's3 (9.09)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 28.42

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index28.42 (24.57)
Research Supply Index1.79 (2.92)
Research Growth Index4.42 (4.65)
Search Engine Demand Index31.58 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (28.42)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Reviews0 (0.00%)6.00%
Case Studies1 (3.13%)4.05%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Observational0 (0.00%)0.25%
Other31 (96.88%)84.16%
Other5 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]